You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DNA Methyltransferase (DNMT) Inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Baltimore (Decitabine, talazoparib)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
    University of Maryland Greenebaum Comprehensive Cancer Center
May 31, 2022

Tumors, Solid Tumors Trial run by the National Cancer Institute (NCI) (aza-TdC)

Recruiting
  • Neoplasms
  • Solid Tumors
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Castration-Resistant Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial in Buffalo

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 27, 2022

Clinical Relevance of DNMT and HDAC Gene SNP on Response to

Completed
  • Myelodysplastic Syndrome
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Aug 11, 2020

    Tumors Trial run by the National Cancer Institute (NCI) (FdCyd + THU)

    Completed
    • Neoplasms
    • FdCyd + THU
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 24, 2023

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL, Recurrent Hodgkin Lymphoma Trial in New York (Decitabine and

    Recruiting
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +5 more
    • Decitabine and Cedazuridine
    • Nivolumab
    • New York, New York
      NY011 Laura and Isaac Perlmutter Cancer Center at NYU Langone
    Jul 8, 2022

    Immunotherapy, Refractory Leukemia, Relapsed Adult AML Trial in Suzhou (Visilizumab)

    Recruiting
    • Immunotherapy
    • +3 more
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Dec 2, 2021

    Effect of DNMT SNPs on DNA Methylation in Primary ITP

    Unknown status
    • Primary Immune Thrombocytopenia
    • Global DNA methylation will be quantified in the DNA samples by colorimetry
    • (no location specified)
    Sep 23, 2019

    MDS, Myeloproliferative Tumor Trial in United States (Azacitidine Subcutaneous Injection or Intravenous Infusion, Pevonedistat

    Active, not recruiting
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasm
    • Azacitidine Subcutaneous Injection or Intravenous Infusion
    • +2 more
    • Miami, Florida
    • +4 more
    Jun 20, 2022

    Tumors, Solid Tumors Trial run by the NCI (TdCyd)

    Suspended
    • Neoplasms
    • Solid Tumors
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 6, 2022

    Glioblastoma Trial in Cleveland (Ibrutinib, Radiation, Temozolomide (TMZ))

    Active, not recruiting
    • Glioblastoma
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Jan 30, 2023

    Mesothelioma, Malignant Mesothelioma (MM), Early-stage Mesothelioma Trial run by the National Cancer Institute (NCI)

    Not yet recruiting
    • Mesothelioma
    • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 1, 2023

    Advanced Solid Tumor, Recurrent Glioma, CNS Lymphoma Trial in United States (PRT811)

    Active, not recruiting
    • Advanced Solid Tumor
    • Recurrent Glioma
    • Denver, Colorado
    • +9 more
    Dec 16, 2022

    MDS/MPN Trial in Nashville (ASTX727, Itacitinib)

    Recruiting
    • MDS/MPN
    • Nashville, Tennessee
      Vanderbilt-Ingram Cancer Center
    Jun 20, 2022

    Tuberculosis, Pulmonary Trial in Houston (Azacitidine Injection)

    Not yet recruiting
    • Tuberculosis, Pulmonary
    • Azacitidine Injection
    • Houston, Texas
      Harris Health System - Ben Taub Hospital
    Sep 1, 2022

    Glioblastoma, Glioma, Malignant Trial in Durham (MT-201-GBM monocyte vaccine)

    Not yet recruiting
    • Glioblastoma
    • Glioma, Malignant
    • MT-201-GBM monocyte vaccine
    • Durham, North Carolina
      The Preston Robert Tisch Brain Tumor Center at Duke University M
    May 25, 2022

    Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (VAL-083, Dianhydrogalactitol)

    Active, not recruiting
    • Glioma
    • +4 more
    • VAL-083, Dianhydrogalactitol
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Mar 23, 2022

    Index Colonoscopy to Predict Polyp Recurrence During

    Completed
    • Colon Polyp
      • (no location specified)
      Oct 3, 2022

      Metastatic Colorectal Cancer Trial (LB-100, Azenosertib)

      Not yet recruiting
      • Metastatic Colorectal Cancer
      • (no location specified)
      Oct 31, 2023

      Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

      Recruiting
      • Advanced Pancreatic Carcinoma
      • +27 more
      • Gainesville, Florida
      • +3 more
      Jan 3, 2023

      Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy,

      Not yet recruiting
      • Advanced Malignant Solid Neoplasm
      • +2 more
      • Biopsy
      • +5 more
      • (no location specified)
      Jan 18, 2023

      Colorectal Tumors, Microsatellite Instability Trial in Milano, Rozzano (temozolomide (induction),, pembrolizumab (treatment))

      Recruiting
      • Colorectal Neoplasms
      • Microsatellite Instability
      • temozolomide (induction),
      • pembrolizumab (treatment)
      • Milano, Italy
      • +3 more
      Sep 28, 2022

      Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Guangzhou (VAL-083 (Dianhydrogalactitol))

      Active, not recruiting
      • Glioma
      • +4 more
      • VAL-083 (Dianhydrogalactitol)
      • Guangzhou, China
        Sun Yat-Sen University Cancer Center
      Mar 23, 2022

      Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma

      Not yet recruiting
      • Anatomic Stage III Breast Cancer AJCC v8
      • +3 more
      • (no location specified)
      Jul 28, 2023

      Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden Trial in Beijing (Chidamide, Decitabine, Chidamide and

      Unknown status
      • Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden
      • Beijing, Beijing, China
        Biotherapeutic Department of Chinese PLA General Hospital
      Dec 3, 2020